7th Annual ANRS HBV Cure Workshop Webinar

POSTED ON: 19 Aug, 2020

 

Because of the COVID-19 pandemic, the seventh HBV cure workshop
organized by the ANRS, originally planned in May in Lyon,
will be scheduled as a webinar on Wednesday September the 16th, 2020.
It will make the state of the art of this rapidly evolving topic.
The program will include plenary lectures with renown speakers and a
roundtable to address the most relevant questions on the science of HBV cure.
Interaction with the audience will be made possible during the webinar.
Registration is free but required.
The webinar will be available in replay until September 17th, 2021!

Register here

Program

 

Contact and registration:
[email protected]
+33 5 57 97 19 19

 

 

Virtual ICE-HBV Workshop On Serum Biomarkers Session 2

POSTED ON: 26 Jul, 2020

ICE-HBV is organizing an virtual and interactive workshop on HBV biomarkers endorsed by the International HBV Meeting. The event is aimed at scientists, clinicians, pharmaceutical and diagnostic industry representatives.  The workshop, chaired by Anna Kramvis and Peter Revill, is put together by the ICE-HBV serum biomarkers working group. Both classic and future biomarkers will be discussed. The workshop will lead to a consensus statement on promising serum biomarkers. 

The workshop will be divided in two sessions, held on Monday Oct 5 and Monday Oct 12, 2020, via Zoom. Both sessions will start at 12PM GMT, go for approximately 2.5 hours each, and will be recorded. More information here.

Free registration is open here.

 

Virtual ICE-HBV Workshop On Serum Biomarkers Session 1

POSTED ON: 22 Jul, 2020

ICE-HBV is organizing an virtual and interactive workshop on HBV biomarkers endorsed by the International HBV Meeting. The event is aimed at scientists, clinicians, pharmaceutical and diagnostic industry representatives.  The workshop, chaired by Anna Kramvis and Peter Revill, is put together by the ICE-HBV serum biomarkers working group. Both classic and future biomarkers will be discussed. The workshop will lead to a consensus statement on promising serum biomarkers. 

The workshop will be divided in two sessions, held on Monday Oct 5 and Monday Oct 12, 2020, via Zoom. Both sessions will start at 12PM GMT, go for approximately 2.5 hours each, and will be recorded. More information here.

Free registration is open here.

 

Community Information Webinar on HBV Cure Research

POSTED ON: 03 Jul, 2020

HBV is a global public health challenge on the same scale as tuberculosis, HIV, and malaria. More than 257 million people worldwide are chronically infected with HBV and nearly 900,000 people died from the disease in 2017. During this session, researchers and community representatives from ICE-HBV and The Hepatitis B Foundation will discuss progress made towards an HBV cure.

Registration is open and free. 

Virtual Conference on Liver Disease in Africa 2020 (COLDA)

POSTED ON: 12 Mar, 2020

The Conference on Liver Disease in Africa (COLDA) is going virtual! COLDA 2020 aims at empowering African healthcare professionals (HCPs) to diagnose, prevent, treat, and achieve a cure for liver diseases for the benefit of patients in Africa. Please visit the meeting website for more information on abstract submission and discounted registration fees: www.COLDA.org

Dr Massimo Levrero presented a HBV cure research update on behalf of ICE-HBV at COLDA.

(Postponed) 7th ANRS Workshop on HBV Cure

POSTED ON: 26 Nov, 2019

Given the evolution of the COVDI-19 epidemic, ANRS has decided to post-pone the workshop. We will keep you informed of the new date once decided.

Hot topics on HBV & HDV Clinical trials, immune exhaustion & immune clearance, cccDNAbiology and targeting, viral integration, viral biomarkers, experimental study models.

This workshop is endorsed by ICE-HBV.

(Postponed) EASL & ICE-HBV Research Think Tank: Overcoming the challenges to cure HBV infections

POSTED ON: 20 Nov, 2019

ICE-HBV & EASL will present their joint HBV Cure Think Tank once again in 2020.

EASL and ICE-HBV invite you to a Research Think Tank on April 15 (8 to11 am) in London to discuss the basic and clinical research gaps that need to be overcome to achieve an HBV cure from the scientific and patient perspectives, as well as explore the latest advances and new insights in translational research towards HBV cure. The Think Tank is open to delegates of the International Liver Congress.

A series of short lectures will be followed by in-depth panel discussions on the following topics:
• Novel approaches to accelerate cure in clinical trials
• Are novel biomarkers advancing HBV cure?
• The patient perspective on HBV cure
• Occult infection vs functional cure
• Which patient populations should be included in clinical trials?
• Manipulating the immune system to achieve an HBV cure
• Standardised approaches to detecting the HBV cccDNA reservoir
• Advances in studies of the liver microenvironment through the use of fine needle aspirants

Find out more here.

HepDART 2019

POSTED ON: 20 Nov, 2019

ICE-HBV and its members will have a strong presence at HepDART 2019, with many important presentations on HBV Cure such as:

Clinical update on drugs for HBV cure* 
Harry Janssen, University of Toronto, Canada
What would an HBV cure look? Endpoints and clinical trial design towards a cure* 
Anna Lok, University of Michigan, USA

Join them in Hawai by registering here.